Association of HLA-DR1 with the allergic response to the major mugwort pollen allergen: Molecular background

BMC Immunology

Volumn 13, Issue , 2012, Pages

  Knapp, Bernhard ^a   Fischer, Gottfried ^a   Van Hemelen, Dries ^a   Fae, Ingrid ^a   Maillere, Bernard ^b   Ebner, Christof ^c   Schreiner, Wolfgang ^a   Bohle, Barbara ^a   Jahn Schmid, Beatrice ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b SERVICE DE CHIMIE BIOORGANIQUE ET DE MARQUAGE   (France)

^c Allergie Ambulatorium Rennweg Vienna   (Austria)

Author keywords

Allergen; Art v 1; HLA association; Molecular dynamics simulation; Peptide MHC class II TCR interaction; T cell recognition

Indexed keywords

HLA DR1 ANTIGEN; HLA DR4 ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTING CELL; ARTEMISIA VULGARIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; COMPUTER MODEL; CONFORMATIONAL TRANSITION; FLOW CYTOMETRY; POLLEN ALLERGY; PROTEIN BINDING; T LYMPHOCYTE;

ALLERGENS; AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS, PLANT; ARTEMISIA; COMPUTER SIMULATION; EPITOPES, T-LYMPHOCYTE; HLA-DR1 ANTIGEN; HLA-DR4 ANTIGEN; HUMANS; HYPERSENSITIVITY; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; PEPTIDES; PLANT PROTEINS; POLLEN; PROTEIN BINDING;

EID: 84864566639     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-13-43     Document Type: Article

References (35)

1. Romagnani S. The role of lymphocytes in allergic disease. J Allergy Clin Immunol 2000, 105:399-408. 10.1067/mai.2000.104575, 10719286.
2. Hammer J, Valsasnini P, Tolba K, Bolin D, Higelin J, Takacs B, Sinigaglia F. Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell 1993, 74:197-203. 10.1016/0092-8674(93)90306-B, 8334703.
3. Panina-Bordignon P, Tan A, Termijtelen A, Demotz S, Corradin G, Lanzavecchia A. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur J Immunol 1989, 19:2237-2242. 10.1002/eji.1830191209, 2481588.
4. Wilson DB, Wilson DH, Schroder K, Pinilla C, Blondelle S, Houghten RA, Garcia KC. Specificity and degeneracy of T cells. Mol Immunol 2004, 40:1047-1055. 10.1016/j.molimm.2003.11.022, 15036909.
5. Ou D, Mitchell LA, Tingle AJ. HLA-DR restrictive supertypes dominate promiscuous T cell recognition: association of multiple HLA-DR molecules with susceptibility to autoimmune diseases. J Rheumatol 1997, 24:253-261.
6. Himly M, Jahn-Schmid B, Dedic A, Kelemen P, Wopfner N, Altmann F, van Ree R, Briza P, Richter K, Ebner C, et al. Art v 1, the major allergen of mugwort pollen, is a modular glycoprotein with a defensin-like and a hydroxyproline-rich domain. Faseb J 2003, 17:106-108.
7. Jahn-Schmid B, Kelemen P, Himly M, Bohle B, Fischer G, Ferreira F, Ebner C. The T cell response to Art v 1, the major mugwort pollen allergen, is dominated by one epitope. J Immunol 2002, 169:6005-6011.
8. Jahn-Schmid B, Fischer GF, Bohle B, Fae I, Gadermaier G, Dedic A, Ferreira F, Ebner C. Antigen presentation of the immunodominant T-cell epitope of the major mugwort pollen allergen, Art v 1, is associated with the expression of HLA-DRB1 *01. J Allergy Clin Immunol 2005, 115:399-404. 10.1016/j.jaci.2004.10.010, 15696102.
9. Jahn-Schmid B, Pickl WF, Bohle B. Interaction of allergens, major histocompatibility complex molecules, and T cell receptors: a 'menage a trois' that opens new avenues for therapeutic intervention in type I allergy. Int Arch Allergy Immunol 2011, 156:27-42. 10.1159/000321904, 21447957.
10. Jahn-Schmid B, Sirven P, Leb V, Pickl WF, Fischer GF, Gadermaier G, Egger M, Ebner C, Ferreira F, Maillere B, et al. Characterization of HLA class II/peptide-TCR interactions of the immunodominant T cell epitope in Art v 1, the major mugwort pollen allergen. J Immunol 2008, 181:3636-3642.
11. Southwood S, Sidney J, Kondo A, del Guercio MF, Appella E, Hoffman S, Kubo RT, Chesnut RW, Grey HM, Sette A. Several common HLA-DR types share largely overlapping peptide binding repertoires. J Immunol 1998, 160:3363-3373.
12. Grunewald J, Shankar N, Wigzell H, Janson CH. An analysis of alpha/beta TCR V gene expression in the human thymus. Int Immunol 1991, 3:699-702. 10.1093/intimm/3.7.699, 1832951.
13. He X, Rosloniec EF, Myers LK, McColgan WL, 3rd Gumanovskaya M, Kang AH, Stuar JM. T cell receptors recognizing type II collagen in HLA-DR-transgenic mice characterized by highly restricted V beta usage. Arthritis Rheum 2004, 50:1996-2004. 10.1002/art.20289, 15188377.
14. Texier C, Pouvelle S, Busson M, Herve M, Charron D, Menez A, Maillere B. HLA-DR restricted peptide candidates for bee venom immunotherapy. J Immunol 2000, 164:3177-3184.
15. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The Protein Data Bank. Nucleic Acids Res 2000, 28:235-242. 10.1093/nar/28.1.235, 102472, 10592235.
16. Zavala-Ruiz Z, Strug I, Walker BD, Norris PJ, Stern LJ. A hairpin turn in a class II MHC-bound peptide orients residues outside the binding groove for T cell recognition. Proc Natl Acad Sci U S A 2004, 101:13279-13284. 10.1073/pnas.0403371101, 516560, 15331779.
17. Knapp B, Omasits U, Schreiner W. Side chain substitution benchmark for peptide/MHC interaction. Protein Sci 2008, 17:977-982. 10.1110/ps.073402508, 2386744, 18434501.
18. Canutescu AA, Shelenkov AA, Dunbrack RL. Jr.: A graph-theory algorithm for rapid protein side-chain prediction. Protein Sci 2003, 12:2001-2014. 10.1110/ps.03154503, 2323997, 12930999.
19. Knapp B, Omasits U, Frantal S, Schreiner W. A critical cross-validation of high throughput structural binding prediction methods for pMHC. J Comput Aided Mol Des 2009, 23:301-307. 10.1007/s10822-009-9259-2, 19194661.
20. Hess B, Kutzner C, VanderSpoel D, Lindahl E. GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. J Chem Theory Comput 2008, 4:435-447.
21. Karplus M, McCammon JA. Molecular dynamics simulations of biomolecules. Nat Struct Biol 2002, 9:646-652. 10.1038/nsb0902-646, 12198485.
22. Omasits U, Knapp B, Neumann M, Steinhauser O, Stockinger H, Kobler R, Schreiner W. Analysis of Key Parameters for Molecular Dynamics of pMHC Molecules. Mol Simulat 2008, 34:781-793.
23. Lee B, Richards FM. The interpretation of protein structures: estimation of static accessibility. J Mol Biol 1971, 55:379-400. 10.1016/0022-2836(71)90324-X, 5551392.
24. Shrake A, Rupley JA. Environment and exposure to solvent of protein atoms. Lysozyme and insulin. J Mol Biol 1973, 79:351-371.
25. Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph 1996, 14:33-38. 27-28, 10.1016/0263-7855(96)00018-5, 8744570.
26. Knapp B, Lederer N, Omasits U, Schreiner W. vmdICE: a plug-in for rapid evaluation of molecular dynamics simulations using VMD. J Comput Chem 2010, 31:2868-2873.
27. Sette A, Sidney J, Oseroff C, del Guercio MF, Southwood S, Arrhenius T, Powell MF, Colon SM, Gaeta FC, Grey HM. HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions. J Immunol 1993, 151:3163-3170.
28. Baker D, Sali A. Protein structure prediction and structural genomics. Science 2001, 294:93-96. 10.1126/science.1065659, 11588250.
29. Ehrenmann F, Kaas Q, Lefranc MP. IMGT/3Dstructure-DB and IMGT/DomainGap Align: a database and a tool for immunoglobulins or antibodies, T cell receptors, MHC, IgSF and MhcSF. Nucleic Acids Res 2010, 38:D301-D307. 10.1093/nar/gkp946, 2808948, 19900967.
30. Chicz RM, Urban RG, Lane WS, Gorga JC, Stern LJ, Vignali DA, Strominger JL. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 1992, 358:764-768. 10.1038/358764a0, 1380674.
31. Mutschlechner S, Egger M, Briza P, Wallner M, Lackner P, Karle A, Vogt AB, Fischer GF, Bohle B, Ferreira F. Naturally processed T cell-activating peptides of the major birch pollen allergen. J Allergy Clin Immunol 2010, 125:711-718. 718 e1-718 e2, 10.1016/j.jaci.2009.10.052, 20132976.
32. Kropshofer H, Vogt AB, Moldenhauer G, Hammer J, Blum JS, Hammerling GJ. Editing of the HLA-DR-peptide repertoire by HLA-DM. Embo J 1996, 15:6144-6154. 452435, 8947036.
33. Reinherz EL, Tan K, Tang L, Kern P, Liu J, Xiong Y, Hussey RE, Smolyar A, Hare B, Zhang R, et al. The crystal structure of a T cell receptor in complex with peptide and MHC class II. Science 1999, 286:1913-1921. 10.1126/science.286.5446.1913, 10583947.
34. Knapp B, Omasits U, Bohle B, Maillere B, Ebner C, Schreiner W, Jahn-Schmid B. 3-Layer-based analysis of peptide-MHC interaction: in silico prediction, peptide binding affinity and T cell activation in a relevant allergen-specific model. Mol Immunol 2009, 46:1839-1844. 10.1016/j.molimm.2009.01.009, 19232439.
35. Knapp B, Omasits U, Schreiner W, Epstein MM. A comparative approach linking molecular dynamics of altered peptide ligands and MHC with in vivo immune responses. PLoS One 2010, 5:e11653. 10.1371/journal.pone.0011653, 2906508, 20657836.